An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia
Top Cited Papers
Open Access
- 15 November 2008
- journal article
- clinical trial
- Published by American Society of Hematology in Blood
- Vol. 112 (10), 4193-4201
- https://doi.org/10.1182/blood-2008-02-134411
Abstract
Patients with cytogenetically normal acute myeloid leukemia (CN-AML) show heterogeneous treatment outcomes. We used gene-expression profiling to deveKeywords
This publication has 34 references indexed in Scilit:
- An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AMLBlood, 2008
- A microarray study of altered gene expression after cytarabine resistance in acute myeloid leukemiaLeukemia, 2007
- Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?Blood, 2006
- Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome predictionBlood, 2006
- Double Induction Containing Either Two Courses or One Course of High-Dose Cytarabine Plus Mitoxantrone and Postremission Therapy by Either Autologous Stem-Cell Transplantation or by Prolonged Maintenance for Acute Myeloid LeukemiaJournal of Clinical Oncology, 2006
- Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B studyBlood, 2006
- Comparison of gene-expression profiles in parallel bone marrow and peripheral blood samples in acute myeloid leukaemia by real-time polymerase chain reactionJournal of Clinical Pathology, 2006
- Distinct gene expression patterns associated with FLT3- and NRAS-activating mutations in acute myeloid leukemia with normal karyotypeOncogene, 2005
- Dose Escalation Studies of Cytarabine, Daunorubicin, and Etoposide With and Without Multidrug Resistance Modulation With PSC-833 in Untreated Adults With Acute Myeloid Leukemia Younger Than 60 Years: Final Induction Results of Cancer and Leukemia Group B Study 9621Journal of Clinical Oncology, 2004
- Semi-Supervised Methods to Predict Patient Survival from Gene Expression DataPLoS Biology, 2004